Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Semorex Inc

Semorex, our mission is to develop and commercialize innovative point-of-use detection and diagnostic products based on our proprietary polymers for selective recognition. Our products will provide rapid and accurate real time information to clinicians and emergency response teams in military, civilian, and environmental operations where immediate action is essential. In addition to saving critical time, our products will lower the costs of and simplify the practice of detection and diagnosis. Our products address markets with significant growth potential; factors fueling this growth include: a shift from centralized to point-of-use diagnosis; the global war on terrorism and homeland security initiatives; an aging population with increased demand for diagnostics and the resulting pressure to lower healthcare costs; and regulations for clean environmentsSemorex Inc., a privately-held U.S. company with an R&D subsidiary, Semorex Technologies Ltd., based in Israel, established operations in 2001 to develop advanced polymeric systems. Semorex was founded by Professor Bernard Green, a professor of pharmaceutical chemistry at the Hebrew University of Jerusalem and a pioneer in catalytic antibody research, and Morris Priwler, an entrepreneur with several years of experience in the biotechnology field. Semorex's innovations are based on the expertise of leading scientists, including Professor Green, the Company's president and chief scientific officer, and Professor Guenter Wulff, a scientific advisor to the Company and one of the leading researchers in the field of molecularly imprinted polymers.


Contact Details:
675 US Highway One
North Brandwick
New Jersey
08902
United States of America
Tel:732 545 7070
Fax:732 745 7270
Email:
WWW:

www.semorex.com/




Loading...

BioNews Results for Semorex Inc:

PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis AG, FedEx Corp., Google Inc., Me
Guru Focus:  Nov 22 2009 3:56PM Matching: inc
Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Cogent Inc, AMERICAN PUBLIC EDUCATION, INC, Whitne
Guru Focus:  Nov 22 2009 5:13PM Matching: inc
N.J. index reaches a yearly high
Asbury Park Press:  Nov 22 2009 12:49PM Matching: inc
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.
Individual.com:  Nov 21 2009 6:41AM Matching: inc
Stocks That Stand Out For Nov. 20th, 2009 Are ARTS, RFMD, CLDS, ACTC
Pharmacy Choice:  Nov 21 2009 1:27PM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Semorex Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 607 times since April 2007, the link to the organisation's website has been followed 87 times

Recent Search Terms used to find this page: semorex | Semorex | semorex | semorex | semore | Semorex Technologies Ltd. | semorex | semorex | semorex | bernard green chemistry | .

Search for more companies in North Brandwick

Search for more companies in New Jersey



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Semorex Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.